Patent US5315015A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5315015A Expired / Lapsed US ⏱️ 0.0 years remaining

Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same

Assignee: Roche Diagnostics Corp
•
Filing: 1992-11-10
•
Granted: 1994-05-24
•
Expires: 2012-11-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula <IMAGE> I wherein F is a fluorescing compound; Y is -NH- or a single covalent bond; Z is a straight or branched alkylene chain of 2 to 10 carbon atoms which is substituted by at least one hydrophilic group; Q is oxygen or sulfur; and X is a ligand-analog, the ligand-analog capable of being recognized by an antibody specific to the corresponding ligand. These compounds have improved properties in fluorescence polarization immunoassays by possessing either a better intensity and/or a larger span.

Inventors

  • 👤 Raymond A. Hui
  • 👤 Kathryn S. Schwenzer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 06:36
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/58; G01N33/582

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 64 words
A compound of the formula: ##STR12## wherein F is a fluorescent group; Y is --NH-- or a single covalent bond; Z is straight or branched alkylene chain of two to ten carbon atoms which is substituted with at least one hydrophilic group; Q is oxygen or sulfur; and X is a ligand-analog capable of being recognized by an antibody specific to the corresponding ligand.
Claim 2
Dependent Claim 64 words
A compound of the formula: ##STR12## wherein F is a fluorescent group; Y is --NH-- or a single covalent bond; Z is straight or branched alkylene chain of two to ten carbon atoms which is substituted with at least one hydrophilic group; Q is oxygen or sulfur; and X is a ligand-analog capable of being recognized by an antibody specific to the corresponding ligand.
Claim 3
Dependent Claim 12 words
The compound according to claim 1, wherein X is a tetrahydrocannabinoid analog.
Claim 4
Dependent Claim 12 words
The compound according to claim 1, wherein X is a carbamazepine analog.
Claim 5
Dependent Claim 12 words
The compound according to claim 1, wherein X is a phenytoin analog.
Claim 6
Dependent Claim 35 words
The compound according to claim 1, wherein the polar hydrophilic group is selected from the group consisting of hydroxy, carboxy, carboxylate esters, carbamyl, thiocarbamyl, amino, substituted amino, sulfino, sulfo, sulfamyl, phosphono, nitro, hydroxyalkoxy, or aminoalkoxy.
Claim 7
Dependent Claim 21 words
The compound according to claim 2, wherein Y is a single covalent bond; Q is oxygen; and Z is 2-hydroxy propylene.
Claim 8
Dependent Claim 14 words
The compound according to claim 2, wherein Y is --NH--, and Q is oxygen.
Claim 9
Dependent Claim 12 words
The compound according to claim 5, wherein the tetrahydrocannabinoid analog is 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-yl.
Claim 10
Dependent Claim 12 words
The compound according to claim 5, wherein the tetrahydrocannabinoid analog is 6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-yl.
Claim 11
Dependent Claim 10 words
The compound according to claim 1, wherein F is 5-fluoresceinyl.
Claim 12
Dependent Claim 10 words
The compound according to claim 1, wherein F is 6-fluoresceinyl.
Claim 13
Dependent Claim 10 words
The compound according to claim 6, wherein F is 5-fluoresceinyl.
Claim 14
Dependent Claim 10 words
The compound according to claim 6, wherein F is 6-fluoresceinyl.

References Cited (Backward Citations)

US4255329A Cited
US4668640A Cited
US4476228A Cited
US4476229A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-05-23 1997-11-22 1998-05-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-05-23 2001-11-22 2002-05-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-05-23 2005-11-22 2006-05-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag